Posicam nets Japanese clearance

Article

Financially troubled PET developer Positron appears to be making progress with its revival plans. The Houston-based firm has received approval from the Japanese Ministry of Health & Welfare for its Posicam-HZ Series PET scanner. The Posicam scanners

Financially troubled PET developer Positron appears to be making progress with its revival plans. The Houston-based firm has received approval from the Japanese Ministry of Health & Welfare for its Posicam-HZ Series PET scanner. The Posicam scanners will be marketed and distributed in Japan exclusively by Imatron Japan, an independent distributor in which ultrafast CT developer Imatron maintains a 24% equity stake. Imatron, of South San Francisco, CA, took over as controlling shareholder in Positron earlier this year (SCAN 2/3/99).

Upon completion of an expected major third-party equity financing deal, Positron will be well positioned to take advantage of PET market opportunities in Japan and the U.S., said Imatron CEO Lewis Meyer. Imatron hopes that the 24 Japanese customers of Imatron’s ultrafast CT scanner will be interested in utilizing PET and ultrafast CT as complementary imaging modalities.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.